• Plasma concentrations of endothelin-1 and C-natriuretic peptide of pregnant women with gestational hypertension

Plasma concentrations of endothelin-1 and C-natriuretic peptide of pregnant women with gestational hypertension

PERINATOLOGIYA I PEDIATRIYA. 2017.1(69):46-50; doi 10.15574/PP.2017.69.46

Plasma concentrations of endothelin-1 and C-natriuretic peptide of pregnant women with gestational hypertension

Bulavenko O. V., Vaskiv O. V.

National Pirogov Memorial Medical University, Ukraine

Purpose — to evaluate the peculiarities of endothelial vasoregulation properties in pregnant women with gestational hypertension, by detecting the serum concentrations of endothelin-1and C-natriuretic peptide and their ratio.

Materials and methods. Total 61 pregnant women were examined and subdivided into three groups. The first group comprised pregnant women with gestational hypertension (n=22), the second group included women with preeclampsia (n=20), and women with normal pregnancy belonged to group III, which was a control group (n=19). The method of enzyme-linked immunoassay by means of reagents of the company «Biomedica» (Germany) was applied to detect the concentration of endothelin-1 and C-natriuretic peptide in the serum of patients.

Results. Serum levels of endothelin-1 and C-natriuretic peptide was significantly higher in women with gestational hypertension (29.1±2.84 pg/ml and 12.2±1.24 ng/ml, respectively) and in the second group of women with preeclampsia (38.1±2.82 pg/ml and 9.1±0.90 ng/ml, respectively) compared with the rates in the control group (15.86±2.10 pg /ml and 6.95±0.68 ng/ml, respectively). There was observed imbalance in the constructor/vasodilator system in patients with preeclampsia resulted in the higher endothelin-1 concentration in blood serum than the C-natriuretic peptide, which is evidenced by the results of their ratio. In particular, their ratio was significantly higher in pregnant women with preeclampsia than in the control group (p<0.05). Pregnant women with gestational hypertension had this ratio slightly higher in comparison with the control group, which can be viewed as a compensatory adaptation due to the increase of C-natriuretic peptide concentration in response to increased production of endothelin-1.

Conclusions. Our analysis suggests that endothelial dysfunction is a characteristic feature of the pregnant women with hypertensive disorders evidenced by the imbalance of vasoregulatory factors, namely by prevailing of the vasoconstrictor component over the vasodilation one.

Key words: gestational hypertension, endothelial dysfunction, endothelin-1, C-natriuretic peptide.

1. Geryak SM, Gumenna ІE. 2014. Pregnancy hypertension: approaches to pathogenetic mechanisms of functional systems reserve utero-placental hemodynamics (literature review). Actual issues of pediatrics, obstetrics and gynecology. 2: 166-170.

2. Mordovin VF, Ripp TM, Sokolov SE. 2001. Dynamics of indicators of endoteliyzavisimy vazodilatation and hypotensive efficiency of enalapril at patients with arterial hypertension. Cardiology. 41; 6: 31-33.

3. Martynov AI, Avetyan NG, Akatova EV. 2005. Endothelium dysfunction at patients with idiopathic hypertensia. Cardiology. 10: 101-104.

4. Kaminsky VV. 2013. The problems of maternal mortality in Ukraine extragenital pathology as a key element for reducing maternal mortality. Materials of III All-Ukrainian scientific-practical conference "The internal pathology in obstetrics and gynecology": 3-5.

5. Kon'kov DG. 2013. The role of signal peptide regulation of vascular tone in the genesis of gestational endoteliopatiyi.Taurian Medical and Biology Journal. 16; 2; 1: 142-147.

6. Konkov DG, Protsepko AA. 2009. Endothelial dysfunction in pregnancy not incubation genesis. Problems, achievements and perspectives of development of medicobiological sciences and practical health care. 145; ІІ: 157-160.

7. Korchinska OO, Fedko RM, Fedko YR. 2013. Features of delivery of women with hypertensive disorders during pregnancy.  Problems of Clinical Pediatrics. 1(19): 30-35.

8. Loskutova TO. 2013. Prevention and tactics of pregnant women at risk of preeclampsia. Actual problems transportnoy medicine. 3: 103-110.

9. Medved VІ. 2010. Selected lectures on extragenital pregnant: 240.

10. Konkov DG, Bulavenko OV, Galich SR. 2012. Local clinical protocol for obstetric care "Predictors, prevention, diagnosis and treatment of hypertensive disorders of pregnancy". Vinnytsia: 96.

11. Starzhinska OL. 2013. The role of C-natriuretic peptide in the functioning of the cardiovascular system problems. Bulletin of Biology and Medicine. 1; 2(99): 31-34

12. Stepanets SO. 2013. Plasma concentrations of C-natriuretic peptide and endothelin-1 in male hypertensive patients with different genotypes piroksysom proliferator-activating receptor gamma. Biomedical and biosocial anthropology. 21: 180-184.

13. Stepankivska GK, Vetskivsky BM, Tymoshenko LV. 2000. Nevidkladni states in akusherstvi and hinekolohiyi. Health: 672.

14. Cabiati M, Del S. 2010. Role of C-type natriuretic peptide (CNP) in disease characterized by endothelial dysfunction. SciTopics. http://www. scitopics. com/.

15. Dechanet C, Fort A, Barbero-Camps E. 2011. Endothelin-dependent vasoconstriction in human uterine artery: application to preeclampsia. PLoS ONE. 6; Iss 1: e16540: 1-8. https://doi.org/10.1371/journal.pone.0016540

16. Gao Z, Zhang Y, Li Z. 2000. Changes of plasma levels of type C natriuretic peptide in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi. 35(3): 139-141. PMid:11775888

17. Willerson JT, Kereiakes DJ. 2003. Endothelial dysfunction. Circulation. 108: 2060-2061. https://doi.org/10.1161/01.CIR.0000099580.72044.83; PMid:14581385